{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:07:02Z","timestamp":1790662022130,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["RSG\u2216R1\u2216180384"],"award-info":[{"award-number":["RSG\u2216R1\u2216180384"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"MRC","doi-asserted-by":"publisher","award":["MR\/K023098\/1"],"award-info":[{"award-number":["MR\/K023098\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neuropharm.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T17:08:46Z","timestamp":1528304926000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity"],"prefix":"10.1016","volume":"142","author":[{"given":"Rachael","family":"Ingram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-7357","authenticated-orcid":false,"given":"Heather","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stafford","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuner A.","family":"Bortolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham L.","family":"Collingridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2047-8269","authenticated-orcid":false,"given":"Arturas","family":"Volianskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.06.008_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0006-3223(97)00556-8","article-title":"Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers","volume":"43","author":"Adler","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib2","series-title":"The Basis of Sensation: the Action of the Sense Organs","author":"Adrian","year":"1928"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib3","first-page":"1","article-title":"Parvalbumin-Positive interneurons regulate neuronal ensembles in visual cortex","author":"Agetsuma","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jneumeth.2006.12.018","article-title":"Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions","volume":"162","author":"Anderson","year":"2007","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/bja\/aei215","article-title":"Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in\u00a0vivo","volume":"95","author":"Benrath","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A\u00a0synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.schres.2014.05.005","article-title":"A\u00a0fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia","volume":"157","author":"Boley","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0091-3057(81)90245-8","article-title":"Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey","volume":"14","author":"Brady","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.6274022","article-title":"Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats","volume":"215","author":"Brady","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)32896-X","article-title":"Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys","volume":"220","author":"Brady","year":"1982","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib13","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.6287578","article-title":"Stereoselective antagonism of phencyclidine's discriminative properties by adenosine receptor agonists","volume":"217","author":"Browne","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib14","article-title":"NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update","author":"Cadinu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1300\/J251v09n01_10","article-title":"PCP and hallucinogens","volume":"9","author":"Carroll","year":"1990","journal-title":"Adv. Alcohol Subst. Abuse"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-3565(25)25691-9","article-title":"The pharmacology of 1-(1-phenylcyclohexyl) piperidine-HCl","volume":"127","author":"Chen","year":"1959","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1460-9568.1993.tb00479.x","article-title":"Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in\u00a0vivo","volume":"5","author":"Chergui","year":"1993","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3940(87)90505-2","article-title":"Mk-801 blocks Nmda receptor-mediated synaptic transmission and long-term potentiation in rat hippocampal slices","volume":"80","author":"Coan","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/jphysiol.1983.sp014478","article-title":"Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus","volume":"334","author":"Collingridge","year":"1983","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.31887\/DCNS.2010.12.3\/jcoyle","article-title":"Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia","volume":"12","author":"Coyle","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(88)90063-8","article-title":"Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner","volume":"92","author":"Davies","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.STR.31.2.347","article-title":"Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist","volume":"31","author":"Davis","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib23","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1523\/JNEUROSCI.19-24-10664.1999","article-title":"Heterogeneity of synaptic plasticity at unitary CA3-CA1 and CA3-CA3 connections in rat hippocampal slice cultures","volume":"19","author":"Debanne","year":"1999","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2018.06.008_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of CI-581, a new dissociative anesthetic, in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/schbul\/sbs011","article-title":"Phencyclidine\/schizophrenia: one view toward the past, the other to the future","volume":"38","author":"Domino","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.2006.124958","article-title":"Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block","volume":"581","author":"Dravid","year":"2007","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib28","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1073\/pnas.89.10.4363","article-title":"Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade","volume":"89","author":"Dudek","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0893-133X(97)00127-9","article-title":"Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity","volume":"18","author":"Farber","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)01894-8","article-title":"The role of N-methyl-D-aspartate receptors in synaptic plasticity of rat visual cortex in\u00a0vitro: effect of sensory experience","volume":"306","author":"Fathollahi","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuropharm.2016.08.010","article-title":"Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus","volume":"112","author":"France","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1213\/00000539-197605000-00010","article-title":"Clinical investigation of a new intravenous anesthetic\u2013etoxadrol hydrochloride (CL-1848; U-37862A)","volume":"55","author":"Frederickson","year":"1976","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1360-0443.1968.tb05252.x","article-title":"Basic concepts and use of cyclazocine in the treatment of narcotic addiction","volume":"63","author":"Freedman","year":"1968","journal-title":"Br. J. Addiction Alcohol Other Drugs"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(84)90404-7","article-title":"The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity","volume":"104","author":"Freeman","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0024-3205(76)90145-4","article-title":"The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes","volume":"18","author":"Garey","year":"1976","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1113\/jphysiol.2003.042598","article-title":"Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+dynamics","volume":"551","author":"Goldberg","year":"2003","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12640-010-9154-6","article-title":"Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress","volume":"18","author":"Grace","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1213\/00000539-195809000-00007","article-title":"A\u00a0study of a 1-aryl cyclo hexyl amine for anesthesia","volume":"37","author":"Greifenstein","year":"1958","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.STR.26.4.602","article-title":"Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial","volume":"26","author":"Grotta","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib41","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1523\/JNEUROSCI.16-06-02034.1996","article-title":"NMDA-dependent modulation of CA1 local circuit inhibition","volume":"16","author":"Grunze","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00402763","article-title":"Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI)","volume":"18","author":"Haertzen","year":"1970","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib43","doi-asserted-by":"crossref","first-page":"e13722","DOI":"10.1371\/journal.pone.0013722","article-title":"Essential role of NMDA receptor channel \u03b54 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine","volume":"5","author":"Hagino","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib44","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0024-3205(82)90288-0","article-title":"Stereospecific binding of 3H-phencyclidine in brain membranes","volume":"30","author":"Hampton","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/jn.1997.77.3.1269","article-title":"Transient synaptic potentiation in the visual cortex. I. Cellular mechanisms","volume":"77","author":"Harsanyi","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib46","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1152\/jn.1997.77.3.1284","article-title":"Transient synaptic potentiation in the visual cortex. II. Developmental regulation","volume":"77","author":"Harsanyi","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2018.01.049","article-title":"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans","author":"Heal","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib48","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-3565(24)39320-6","article-title":"Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors","volume":"293","author":"Hernandez","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib49","series-title":"Excitatory Amino Acids: Clinical Results with Antagonists","author":"Herrling","year":"1997"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00422419","article-title":"Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon","volume":"73","author":"Herrling","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/322265a0","article-title":"Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism","volume":"322","author":"Herron","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","article-title":"Cloned glutamate receptors","volume":"17","author":"Hollmann","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00432758","article-title":"Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey","volume":"77","author":"Holtzman","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(25)32225-1","article-title":"Phencyclidine-like discriminative effects of opioids in the rat","volume":"214","author":"Holtzman","year":"1980","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib55","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)05201-2","article-title":"Actions and addiction liabilities of dromoran derivatives in man","volume":"107","author":"Isbell","year":"1953","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib56","series-title":"The Principles of Psychology","author":"James","year":"1890"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(25)27721-7","article-title":"The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone)","volume":"157","author":"Jasinski","year":"1967","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib58","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/schbul\/sbs069","article-title":"Has an angel shown the way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(97)00413-9","article-title":"Muscimol-like discriminative stimulus effects of GABA agonists in rats","volume":"59","author":"Jones","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3940(93)90341-H","article-title":"Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation","volume":"149","author":"Jones","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuropharm.2016.08.004","article-title":"Ephenidine: a new psychoactive agent with ketamine-like NMDA receptor antagonist properties","volume":"112","author":"Kang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib63","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(25)26706-4","article-title":"Studies of analgesic drugs. Viii. A narcotic antagonist analgesic without psychotomimetic effects","volume":"143","author":"Keats","year":"1964","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib66","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pbb.2013.05.005","article-title":"Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats","volume":"109","author":"Kotermanski","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib68","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1113\/jphysiol.2009.176297","article-title":"Memantine binding to a superficial site on NMDA receptors contributes to partial trapping","volume":"587","author":"Kotermanski","year":"2009","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib69","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3181\/00379727-118-29840","article-title":"Analgesic and psychotomimetic properties of dexoxadrol","volume":"118","author":"Lasagna","year":"1965","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib70","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.neuron.2017.02.033","article-title":"Parvalbumin interneurons modulate striatal output and enhance performance during associative learning","volume":"93","author":"Lee","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.conb.2013.11.003","article-title":"Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia","volume":"26","author":"Lewis","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib72","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/bja\/56.10.1143","article-title":"Effects of ketamine and three other anaesthetics on spinal reflexes and inhibitions in the cat","volume":"56","author":"Lodge","year":"1984","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0304-3940(85)90271-X","article-title":"Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in\u00a0vitro","volume":"56","author":"Lodge","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib74","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1111\/bph.13222","article-title":"Ketamine and phencyclidine: the good, the bad and the unexpected","volume":"172","author":"Lodge","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib75","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5419-08.2009","article-title":"A\u00a0loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia","volume":"29","author":"Lodge","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug; sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib77","first-page":"241","article-title":"The phencyclidine psychosis: phenomenology and treatment","author":"Luisada","year":"1978","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/jn.1987.58.2.251","article-title":"Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine","volume":"58","author":"MacDonald","year":"1987","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib79","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00326a019","article-title":"The synthesis of phencyclidine and other 1-arylcyclohexylamines","volume":"8","author":"Maddox","year":"1965","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0896-6273(91)90121-F","article-title":"Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus","volume":"6","author":"Malenka","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(98)00945-5","article-title":"5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex","volume":"367","author":"Marek","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib82","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0028-3908(85)90128-5","article-title":"Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in\u00a0vitro","volume":"24","author":"Martin","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.neuro.23.1.649","article-title":"Synaptic plasticity and memory: an evaluation of the hypothesis","volume":"23","author":"Martin","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00499836","article-title":"Differential electrophysiological and behavioral responses to optically active derivatives of phencyclidine","volume":"315","author":"Marwaha","year":"1981","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/309261a0","article-title":"Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones","volume":"309","author":"Mayer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib87","first-page":"21","article-title":"General anesthetic and other pharmacological properties of 2-(o-chlorophenyl)-2-methylamino cyclohexanone hcl (ci-58l)","volume":"5","author":"McCarthy","year":"1965","journal-title":"J.\u00a0N. Drugs"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib88","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/0006-2952(84)90133-3","article-title":"Phencyclidine receptors in rat brain cortex","volume":"33","author":"Mendelsohn","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.06.008_bib89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005053-195907000-00006","article-title":"A\u00a0new drug causing symptoms of sensory deprivation","volume":"129","author":"Meyer","year":"1959","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cell.2017.08.050","article-title":"Parvalbumin and somatostatin interneurons control different space-coding networks in the medial entorhinal cortex","volume":"171","author":"Miao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib91","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1073\/pnas.0809302105","article-title":"NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex","volume":"105","author":"Middleton","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in \u03b17 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib93","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/schbul\/sbs075","article-title":"Capturing the angel in \u201cangel dust\u201d: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans","volume":"38","author":"Moghaddam","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib94","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib95","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","article-title":"Heteromeric NMDA receptors: molecular and functional distinction of subtypes","volume":"256","author":"Monyer","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","author":"Morris","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib98","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00001756-199312000-00035","article-title":"Synaptic potentiation in the rat dentate gyrus during exploratory learning","volume":"5","author":"Moser","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib99","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/lm.1.1.55","article-title":"Potentiation of dentate synapses initiated by exploratory learning in rats: dissociation from brain temperature, motor activity, and arousal","volume":"1","author":"Moser","year":"1994","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2005.12.002","article-title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","volume":"6","author":"Muir","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib101","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/0024-3205(84)90121-8","article-title":"Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes","volume":"34","author":"Murray","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib102","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib103","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2017.10.012","article-title":"Cortical interneurons differentially shape frequency tuning following adaptation","volume":"21","author":"Natan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/307462a0","article-title":"Magnesium gates glutamate-activated channels in mouse central neurones","volume":"307","author":"Nowak","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0893-133X(95)00079-S","article-title":"NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia","volume":"13","author":"Olney","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2018.06.008_bib107","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1469-7793.1998.503bq.x","article-title":"Short-term facilitation evoked during brief afferent tetani is not altered by long-term potentiation in the Guinea-pig hippocampal CA1 region","volume":"508","author":"Pananceau","year":"1998","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib108","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/0024-3205(84)90536-8","article-title":"The effects of ketamine, phencyclidine and lidocaine on catecholamine secretion from cultured bovine adrenal chromaffin cells","volume":"35","author":"Purifoy","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib109","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1073\/pnas.78.9.5881","article-title":"Phencyclidine (angel dust)\/sigma \u201copiate\u201d receptor: visualization by tritium-sensitive film","volume":"78","author":"Quirion","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177036","article-title":"Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation","volume":"12","author":"Rame","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2014.03.004","article-title":"Clinically relevant concentrations of ketamine mainly affect long-term potentiation rather than basal excitatory synaptic transmission and do not change paired-pulse facilitation in mouse hippocampal slices","volume":"1560","author":"Ribeiro","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib112","first-page":"570","article-title":"Les origines etles modalit\u00e9s de la memoire","volume":"XXI","author":"Richet","year":"1886","journal-title":"Revue Philosophique"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib1a","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.aah7011","article-title":"Reactivation of latent working memories with transcranial magnetic stimulation","volume":"354","author":"Rose","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/322263a0","article-title":"Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors","volume":"322","author":"Salt","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib114","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/jpet.115.230391","article-title":"GluN2D N-Methyl-d-Aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia","volume":"356","author":"Sapkota","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/jn.1997.78.1.321","article-title":"Differing mechanisms of expression for short- and long-term potentiation","volume":"78","author":"Schulz","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib116","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1523\/JNEUROSCI.5736-11.2012","article-title":"NMDA receptors with incomplete Mg2\u207a block enable low-frequency transmission through the cerebellar cortex","volume":"32","author":"Schwartz","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib117","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1523\/JNEUROSCI.19-04-01236.1999","article-title":"Hippocampal long-term potentiation preserves the fidelity of postsynaptic responses to presynaptic bursts","volume":"19","author":"Selig","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib118","article-title":"Studies with psychedelic drugs in human volunteers","author":"Sellers","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib119","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3565(25)33166-6","article-title":"Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats","volume":"222","author":"Shannon","year":"1982","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(82)90207-2","article-title":"Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats","volume":"84","author":"Shannon","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib121","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(25)32463-8","article-title":"Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat","volume":"216","author":"Shannon","year":"1981","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib122","first-page":"272","article-title":"Phencyclidine, criminal behavior, and the defense of diminished capacity","author":"Siegel","year":"1978","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib123","first-page":"119","article-title":"Phencyclidine and ketamine intoxication: a study of four populations of recreational users","author":"Siegel","year":"1978","journal-title":"NIDA Res. Monogr."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2018.06.008_bib124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0024-3205(83)90492-7","article-title":"Characterization of specific sigma opiate\/phencyclidine (PCP)-binding sites in the human brain","volume":"33","author":"Sircar","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib126","series-title":"Psychedelics Encyclopedia","author":"Stafford","year":"1977"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib127","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mp.2017.47","article-title":"Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia","volume":"22","author":"Steullet","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-8993(83)91180-0","article-title":"Blockade of long-term potentiation by phencyclidine and sigma opiates in the hippocampus in\u00a0vivo and in\u00a0vitro","volume":"280","author":"Stringer","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0006-8993(83)91244-1","article-title":"Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine","volume":"258","author":"Stringer","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib130","first-page":"1","article-title":"ScienceDirect Triheteromeric NMDA receptors: from structure to synaptic physiology","volume":"2","author":"Stroebel","year":"2018","journal-title":"Curr. Opin. Psychol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0091-3057(84)90244-2","article-title":"Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP)","volume":"20","author":"Tang","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib132","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuron.2006.09.020","article-title":"Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology","volume":"52","author":"Uhlhaas","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/jn.1998.79.2.555","article-title":"Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors","volume":"79","author":"Vicini","year":"1998","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib134","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(25)33390-2","article-title":"Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices","volume":"223","author":"Vickroy","year":"1982","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib135","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1073\/pnas.76.9.4678","article-title":"Interaction of phencyclidine (\u201cangel dust\u201d) with a specific receptor in rat brain membranes","volume":"76","author":"Vincent","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib136","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1113\/jphysiol.2012.247296","article-title":"Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in\u00a0vitro","volume":"591","author":"Volianskis","year":"2013","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib137","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.7717\/peerj.3","article-title":"The roles of STP and LTP in synaptic encoding","volume":"1","author":"Volianskis","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brainres.2015.01.016","article-title":"Long-term potentiation and the role of N-methyl-D-aspartate receptors","volume":"1621","author":"Volianskis","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib139","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/jphysiol.2003.044214","article-title":"Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus","volume":"550","author":"Volianskis","year":"2003","journal-title":"J.\u00a0Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib140","first-page":"642","volume":"vol. 11","author":"Vollenweider","year":"2010"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib141","doi-asserted-by":"crossref","first-page":"e0157021","DOI":"10.1371\/journal.pone.0157021","article-title":"Pharmacological investigations of the dissociative \u201clegal highs\u201d diphenidine, methoxphenidine and analogues","volume":"11","author":"Wallach","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib142","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0893-133X(99)00163-3","article-title":"Antagonism of a PCP drug discrimination by hallucinogens and related drugs","volume":"22","author":"West","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib143","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0022-3565(25)33346-X","article-title":"Properties of pentazocine as a discriminative stimulus in the squirrel monkey","volume":"223","author":"White","year":"1982","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib144","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2013its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib146","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2013.01.016","article-title":"Neuropharmacology","volume":"74","author":"Wyllie","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib147","doi-asserted-by":"crossref","first-page":"e27868","DOI":"10.7554\/eLife.27868","article-title":"Parvalbumin-positive interneurons mediate neocortical-hippocampal interactions that are necessary for memory consolidation","volume":"6","author":"Xia","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib148","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1756-6606-6-56","article-title":"Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity","volume":"6","author":"Yamamoto","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib149","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3940(92)90783-4","article-title":"Inhibitory effects of psychotomimetic sigma ligands on nicotine-induced K+ flux from differentiated PC12 cells","volume":"147","author":"Yamamoto","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib150","doi-asserted-by":"crossref","first-page":"E1627","DOI":"10.1073\/pnas.1720855115","article-title":"Entorhinal fast-spiking speed cells project to the hippocampus","volume":"115","author":"Ye","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib151","series-title":"Recreational Drugs","year":"1977"},{"key":"10.1016\/j.neuropharm.2018.06.008_bib152","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0006-8993(92)91273-H","article-title":"Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses","volume":"593","author":"Zhang","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0026-895X(25)14126-6","article-title":"Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites","volume":"20","author":"Zukin","year":"1981","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib154","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0024-3205(82)90368-X","article-title":"Differing stereospecificities distinguish opiate receptor subtypes","volume":"31","author":"Zukin","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-8993(84)91326-X","article-title":"Behavioral and biochemical stereoselectivity of sigma opiate\/PCP receptors","volume":"294","author":"Zukin","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib156","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.76.10.5372","article-title":"Specific [3H]phencyclidine binding in rat central nervous system","volume":"76","author":"Zukin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.06.008_bib157","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1073\/pnas.0813415106","article-title":"Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior","volume":"106","author":"Zweifel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818302843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:41:46Z","timestamp":1751676106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818302843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":158,"alternative-id":["S0028390818302843"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}